|
Trinity Biotech shares rise as FDA approves HIV test Yahoo! Finance Shares of Trinity Biotech PLC (Nasdaq:TRIB) climbed Monday after the Irish company announced it had won approval to market its rapid HIV test in the U.S. Meanwhile, shares of a key U.S. competitor in the rapid HIV test market, OraSure Technologies Inc. (Nasdaq:OSUR), slid. The US Food and Drug Administration approved Trinity Biotech's 10-minute, one- step Uni-Gold Recombigen test to detect HIV antibodies in human serum, plasma or whole blood — the first device to be approved for use with all three sample types, the company said.
—Posted: December 29, 2003
More news headlines: This week | Last week | Search archive
|
